ABOUT VOYAGEUR
Voyageur Pharmaceuticals Ltd. is a drug manufacturing company focused on radiographic contrast media products. Voyageur is developing barium and iodine generic radiographic drugs, for the healthcare market. Voyageur is unique, as it is sourcing its own main ingredients from its own mineral deposits. Voyageur is building a business model that will allow it to be the only fully integrated company in the radiographic market place.
Near-term cash flow will be achieved through third party pharmaceutical manufacturing, sourcing third party minerals, turn key manufacturing, bottling and distribution of barium and iodine radiographic pharmaceutical drugs for MRI, X-ray and CT scan applications.
By implementing our “From The Earth to The Bottle” strategy, Voyageur will have the greatest competitive advantage, by having the lowest ingredient costs in the industry for our pharmaceutical product line.
Cash Flow Strategy For Growth
Voyageur Business Strategy 2020
Voyageur Creates Strategic Agreement With THINQ For Future Drug Development
News ThinQ Voy July 27 2020
Shareholder Update June 2020
Shareholder Update 2020
Fullerene Study – Fullerenes in biology and medicine
Fullerene Study - Fullerenes in biology and medicine [...]
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company – $0.39 Fair Market Value Target
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior [...]
Rare high-grade barium sulfate & iodine discovery spurs pharmaceutical JV
Resource World Magazine - Resource World - Voyageur Minerals